To confirm their identity, firstly we performed IHC with standard immune cell markers (CD45, CD68, and CD8) and S100A9 on tumor sections, distinguishing tumor core and necrotic areas (Figure 4A–E). The gene discussed is S100A9; the disease is neoplasm.